THC BioMed: J.D. Springett Joins Advisory Board.

THC BioMed: J.D. Springett Joins Advisory Board.

ID: 409949

(firmenpresse) -
J.D. Springett Joins Advisory Board.

Vancouver, B.C. - (July 29, 2015) THC BioMed Intl Ltd. (THC) is pleased to announce it has appointed Mr. J. D. Springett to the company's newly formed advisory board. Mr. Springett brings 7 years experience in the newly emerging Medical Cannabis industry, beginning with Cannabis Science in 2008. He has extensive knowledge and experience in the medical marijuana sector and is highly sought after as a design and training expert for licensed medical marijuana facilities. He has been a valuable consultant for several companies seeking a MMPR license. Mr. Springett will be a valuable addition to our highly trained scientific consulting team.

THCs vision is to be on the leading edge of scientific research and development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com

President and CEO:
John Miller
THC Biomed Intl Ltd. T: 604 682-1643E: info(at)thcbiomed.com

THC BIOMED INTL LTD.
Suite 1100 - 888 Dunsmuir StreetVancouver, BC V6C 3K4
www.thcbiomed.com
THC.CSE, THCBF-OTC,TFHC.F



Forward-Looking Information:

This press release contains certain forward-looking information within the meaning of applicable securities law. The forward looking statements include that (i) Mr. Springett will be valuable in helping the Company achieve its goal of global growth and (ii) As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Forward-looking information is frequently characterized by words such as plan, expect, project, intend, believe, anticipate, estimate, may, will, would, potential, proposed and other similar words, or statements that certain events or conditions may or will occur. These statements are only predictions. These statements are based on expectations and assumptions made by the management of THC at the date the information is provided, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing THC and its business and affairs, readers should refer to THCs Listing Statement, Financial Statements and its Managements Discussion and Analysis on www.sedar.com.







Unternehmensinformation / Kurzprofil:
Leseranfragen:






Bereitgestellt von Benutzer: irw
Datum: 29.07.2015 - 14:06 Uhr
Sprache: Deutsch
News-ID 409949
Anzahl Zeichen: 2944

contact information:
Town:

Wien



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 174 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"THC BioMed: J.D. Springett Joins Advisory Board.
"
steht unter der journalistisch-redaktionellen Verantwortung von

THC BioMed Intl Ltd. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von THC BioMed Intl Ltd.



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z